Inventage Lab will participate in CPHI Milan 2026 (CPHI Europe), taking place October 6–8, 2026 at Fiera Milano in Milan, Italy.
Organized by Informa Markets, CPHI is the world's largest pharmaceutical industry exhibition and partnering event, drawing over 62,000 attendees and 2,900+ exhibiting companies from more than 166 countries in 2025. Spanning APIs, bioproduction, and contract development and manufacturing, it brings together the full pharmaceutical value chain in one place.
Inventage Lab is a clinical-stage biotech developing next-generation drug delivery platforms based on its proprietary microfluidic technology. At CPHI Milan 2026, the company will focus on DrugFluidic®, its long-acting injectable (LAI) platform for small molecules and peptides, and BioFluidic™, its platform for subcutaneous (SC) formulation optimization of antibody and protein therapeutics.
Inventage Lab will attend with a focus on one-to-one partnering meetings, pursuing co-development, licensing, and CDMO partnership discussions. We welcome meeting requests from pharmaceutical and biotech companies interested in global partnering.
